Navigation Links
Boston University School of Medicine researchers receive NIMH brain awards
Date:2/7/2011

(Boston) - Two Boston University School of Medicine (BUSM) faculty members, Pietro Cottone, PhD, an assistant professor of pharmacology and psychiatry and Michael Silverstein, MD, an associate professor of pediatrics, were each awarded the prestigious National Institute of Mental Health (NIMH) Biobehavioral Research Awards for Innovative New Scientisits (BRAINS) grant with ten other investigators from around the country. The BRAINS award called for innovative and groundbreaking research projects from early stage investigators to explore the complex mechanisms underlying mental disorders or novel treatments and prevention strategies.

The BRAINS initiative was created to support the research programs and career development of outstanding scientists who are in the early, formative stages of their careers and who plan to make a long term commitment to research most relevant to NIMH. This award seeks to assist these individuals in launching an innovative clinical, translational, or basic research program that holds the potential to profoundly transform the understanding, diagnosis, treatment, or prevention of mental disorders.

Cottone, whose research explores the neural mechanisms underlying addictive disorders summarizes his proposal. "We propose that a history of dieting and relapse represents a vicious circle between stress and compulsive eating. In other words, the next attempt to avoid junk food is going to be more painful and stressful than the previous one, and the likelihood of relapse will progressively increase. We propose that during dieting the endocannabinoids (chemicals of the brains that protect from stress and promote the consumption of our favorite foods) are released to try to fight this stressful condition but on the other side they also increase our craving for junk food. Therefore blockade of the endocannabinoid action on one hand reduces compulsive eating, but on the other hand it induces anxiety and depression. This proposal will clarify the mechanisms linking eating disorders and obesity to anxiety and mood disorders."

Silverstein is studying maternal depression and is exploring detection and treatment options in the community setting, using for example, programs like Head Start and Early Intervention. He is experimenting with motivational interviewing and cognitive behavior therapy. "Our project is a community-based maternal depression prevention trial that enrolls young mothers at risk for developing major depressive disorder. The project takes place in Head Start and aims to enroll 230 women over five years."

"While these awards fund specific projects, they are truly an investment in specific people," said NIMH director Thomas R. Insel, MD. Inspired by the success of the NIH Director's Pioneer Awards and New Innovator Awards, both of which are designed to provide support for innovative research that has the potential for unusually high impact on health science. "The hope is that BRAINS awards will give early stage investigators enough flexibility to take risks on tough problems that are central to neuroscience and to the understanding of mental illness, such as the nature and development of neural circuits and the genetic factors and environmental influences that both shape and disrupt them," he adds.

The BRAINS program awards up to $1.625 million over five years for early career scientists focusing on a gap area identified in the Institute's Strategic Plan.


'/>"/>

Contact: Gina DiGravio
gina.digravio@bmc.org
617-638-8480
Boston University Medical Center
Source:Eurekalert

Related biology news :

1. Boston College chemistry professor Udayan Mohanty receives a 2009 Guggenheim Fellowship
2. Boston University biomedical engineers teach bacteria to count
3. Boston University engineer to use $2.5 million NIH grant to cells reaction to physical force
4. Boston University School of Medicine researcher awarded the 2010 Avanti Award in Lipids
5. Boston University scientists first to see RNA network in live bacterial cells
6. Grant brings real-world science to Boston classrooms
7. Boston University reseachers develop faster, cheaper DNA sequencing method
8. Worlds largest meeting of ear, nose and throat doctors to convene in Boston Sept. 26-29, 2010
9. Boston Univ., Veterans Affairs find sports brain trauma may cause disease mimicking ALS
10. Boston University School of Medicine professor receives AACCs Van Slyke Award
11. Rice University establishes National Corrosion Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... , April 5, 2017  The Allen Institute for ... Cell Explorer: a one-of-a-kind portal and dynamic digital window ... imaging data, the first application of deep learning to ... stem cell lines and a growing suite of powerful ... for these and future publicly available resources created and ...
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/29/2017)... 29, 2017  higi, the health IT company that ... North America , today announced a Series B ... of EveryMove. The new investment and acquisition accelerates higi,s ... to transform population health activities through the collection and ... higi collects and secures data today on behalf ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... The ... context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The ... transformative for performing systematic gain-of-function studies. , This complement to loss-of-function studies, ...
(Date:10/11/2017)... 2017  VMS BioMarketing, a leading provider of patient support ... Nurse Educator (CNE) network, which will launch this week. The ... health care professionals to enhance the patient care experience by ... other health care professionals to help women who have been ... ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal ... the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and ... San Diego Rotary Club. The event entitled “Stem Cells and Their ... 300+ attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: Peter ...
Breaking Biology Technology: